Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Craig Millian Insider Profile
4 Followers
Craig Millian, Chief Executive Officer at HLS Therapeutics Inc, holds 12.50K shares in HLS Therapeutics Inc (Ticker: TSE:HLS). Most recently, Craig Millian Bought C$2,500 shares of HLS Therapeutics Inc on May 17, 2024 for an estimated value of 7.25K.
Craig Millian HLS Therapeutics Inc (HLS)Chief Executive Officer
HLS Therapeutics Inc (HLS)
Chief Executive Officer
Ranked #65,299 out of 100,202 Corporate Insiders
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-10.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Executive Officer
Roles that Craig Millian holds in companies
Most Profitable Insider Trade
The most profitable trade made by Craig Millian
Craig Millian's Trading History
List of latest transactions for each holding click on a transaction to see Craig Millian's performance on stock
You May Also Like
Craig Millian insider profile FAQ
What is the percentage of profitable transactions made by Craig Millian?
The percentage of profitable transactions made by Craig Millian is 0%.
What is the average return per transaction made by Craig Millian?
The average return per transaction made by Craig Millian is -10.10%.
What stocks does Craig Millian hold?
Craig Millian holds: TSE:HLS stocks.
What was Craig Millian’s latest transaction?
Craig Millian latest transaction was an Informative Buy of C$7.25K.
What was Craig Millian's most profitable transaction?
Craig Millian’s most profitable transaction was an Informative Buy of TSE:HLS stock on May 17, 2024. The return on the trade was -2.50%.
What is Craig Millian's role in HLS Therapeutics Inc?
Craig Millian's role in HLS Therapeutics Inc is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.